Educational intervention to adopt selective laser trabeculoplasty as first-line glaucoma treatment: Randomized controlled trial: Educational intervention on selective laser trabeculoplasty
CONCLUSIONS: A slideshow and video-based educational intervention may positively enhance patient adoption of SLT.Clinical trial registration name, number, URL: Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment, NCT03365778, https://clinicaltrials.gov/ct2/show/NCT03365778.PMID:34041935 | DOI:10.1177/11206721211018365 (Source: European Journal of Ophthalmology)
Source: European Journal of Ophthalmology - May 27, 2021 Category: Opthalmology Authors: Evelyn Tran Carina Sanvicente Lisa A Hark Jonathan S Myers Qiang Zhang Eric J Shiuey Judie Tran Lucas Bonafede Rose A Hamershock Colleen Withers L Jay Katz Source Type: research
Educational intervention to adopt selective laser trabeculoplasty as first-line glaucoma treatment: Randomized controlled trial: Educational intervention on selective laser trabeculoplasty
CONCLUSIONS: A slideshow and video-based educational intervention may positively enhance patient adoption of SLT.Clinical trial registration name, number, URL: Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment, NCT03365778, https://clinicaltrials.gov/ct2/show/NCT03365778.PMID:34041935 | DOI:10.1177/11206721211018365 (Source: European Journal of Ophthalmology)
Source: European Journal of Ophthalmology - May 27, 2021 Category: Opthalmology Authors: Evelyn Tran Carina Sanvicente Lisa A Hark Jonathan S Myers Qiang Zhang Eric J Shiuey Judie Tran Lucas Bonafede Rose A Hamershock Colleen Withers L Jay Katz Source Type: research
Educational intervention to adopt selective laser trabeculoplasty as first-line glaucoma treatment: Randomized controlled trial: Educational intervention on selective laser trabeculoplasty
CONCLUSIONS: A slideshow and video-based educational intervention may positively enhance patient adoption of SLT.Clinical trial registration name, number, URL: Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment, NCT03365778, https://clinicaltrials.gov/ct2/show/NCT03365778.PMID:34041935 | DOI:10.1177/11206721211018365 (Source: European Journal of Ophthalmology)
Source: European Journal of Ophthalmology - May 27, 2021 Category: Opthalmology Authors: Evelyn Tran Carina Sanvicente Lisa A Hark Jonathan S Myers Qiang Zhang Eric J Shiuey Judie Tran Lucas Bonafede Rose A Hamershock Colleen Withers L Jay Katz Source Type: research
Educational intervention to adopt selective laser trabeculoplasty as first-line glaucoma treatment: Randomized controlled trial: Educational intervention on selective laser trabeculoplasty
CONCLUSIONS: A slideshow and video-based educational intervention may positively enhance patient adoption of SLT.Clinical trial registration name, number, URL: Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment, NCT03365778, https://clinicaltrials.gov/ct2/show/NCT03365778.PMID:34041935 | DOI:10.1177/11206721211018365 (Source: European Journal of Ophthalmology)
Source: European Journal of Ophthalmology - May 27, 2021 Category: Opthalmology Authors: Evelyn Tran Carina Sanvicente Lisa A Hark Jonathan S Myers Qiang Zhang Eric J Shiuey Judie Tran Lucas Bonafede Rose A Hamershock Colleen Withers L Jay Katz Source Type: research
Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China – A Randomized Controlled Trial: Design and Baseline Characteristics
To describe the baseline characteristics of a trial to evaluate whether selective laser trabeculoplasty (SLT), as a first-line treatment, provides superior economic and health-related quality of life outcomes to medical treatment in China. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - May 2, 2021 Category: Opthalmology Authors: Yangfan Yang, Yuzhen Jiang, Shitong Huang, Xinyi Zhang, Neil Nathwani, Mingkai Lin, Xing Liu, Xiulan Zhang, Yanmei Fan, Jiangang Xu, Gus Gazzard, Minbin Yu, Light China Trial Study Group Tags: Original Articles Source Type: research
Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China A Randomized Controlled Trial: Design and Baseline Characteristics
: To describe the baseline characteristics of a trial to evaluate whether selective laser trabeculoplasty (SLT), as a first-line treatment, provides superior economic and health-related quality of life outcomes to medical treatment in China. (Source: American Journal of Ophthalmology)
Source: American Journal of Ophthalmology - May 2, 2021 Category: Opthalmology Authors: Yangfan Yang, Yuzhen Jiang, Shitong Huang, Xinyi Zhang, Neil Nathwani, Mingkai Lin, Xing Liu, Xiulan Zhang, Yanmei Fan, Jiangang Xu, Gus Gazzard, Minbin Yu Source Type: research
Relationship between intraocular pressure responses to selective laser trabeculoplasty and excisional goniotomy with Kahook Dual Blade combined with phacoemulsification in glaucomatous eyes
CONCLUSION: No relationship between success of SLT and subsequent KDB was observed. However, patients with history of failed SLT still benefited from subsequent KDB.PMID:33839069 | DOI:10.1016/j.jcjo.2021.02.040 (Source: Canadian Journal of Ophthalmology)
Source: Canadian Journal of Ophthalmology - April 11, 2021 Category: Opthalmology Authors: Joshua King Dayeong Lee Samuel Thomsen Matthew T Hirabayashi Jella An Source Type: research
Relationship between intraocular pressure responses to selective laser trabeculoplasty and excisional goniotomy with Kahook Dual Blade combined with phacoemulsification in glaucomatous eyes
CONCLUSION: No relationship between success of SLT and subsequent KDB was observed. However, patients with history of failed SLT still benefited from subsequent KDB.PMID:33839069 | DOI:10.1016/j.jcjo.2021.02.040 (Source: Canadian Journal of Ophthalmology)
Source: Canadian Journal of Ophthalmology - April 11, 2021 Category: Opthalmology Authors: Joshua King Dayeong Lee Samuel Thomsen Matthew T Hirabayashi Jella An Source Type: research
Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
CONCLUSIONS: Afro-Caribbean patients with OAG at risk for progression can achieve clinically and statistically significant reductions in IOP or medications through up to 24 months following a single 360° SLT treatment.TRIAL REGISTRATION NUMBER: NCT02375009.PMID:33836987 | DOI:10.1136/bjophthalmol-2020-317117 (Source: The British Journal of Ophthalmology)
Source: The British Journal of Ophthalmology - April 10, 2021 Category: Opthalmology Authors: Tony Realini Hazel Shillingford-Ricketts Darra Burt Goundappa K Balasubramani Source Type: research
Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
CONCLUSIONS: Afro-Caribbean patients with OAG at risk for progression can achieve clinically and statistically significant reductions in IOP or medications through up to 24 months following a single 360° SLT treatment.TRIAL REGISTRATION NUMBER: NCT02375009.PMID:33836987 | DOI:10.1136/bjophthalmol-2020-317117 (Source: The British Journal of Ophthalmology)
Source: The British Journal of Ophthalmology - April 10, 2021 Category: Opthalmology Authors: Tony Realini Hazel Shillingford-Ricketts Darra Burt Goundappa K Balasubramani Source Type: research
Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression
CONCLUSIONS: Afro-Caribbean patients with OAG at risk for progression can achieve clinically and statistically significant reductions in IOP or medications through up to 24 months following a single 360° SLT treatment.TRIAL REGISTRATION NUMBER: NCT02375009.PMID:33836987 | DOI:10.1136/bjophthalmol-2020-317117 (Source: The British Journal of Ophthalmology)
Source: The British Journal of Ophthalmology - April 10, 2021 Category: Opthalmology Authors: Tony Realini Hazel Shillingford-Ricketts Darra Burt Goundappa K Balasubramani Source Type: research
Effectiveness of Selective Laser Trabeculoplasty Applied to 360 ° vs. 180° of the Angle
CONCLUSIONS: 360° of SLT application seems to provide for greater long-term IOP control than 180° of application without putting patients at an elevated risk for postoperative IOP spikes.PMID:33643665 | PMC:PMC7902141 | DOI:10.1155/2021/8860601 (Source: Journal of Ophthalmology)
Source: Journal of Ophthalmology - March 1, 2021 Category: Opthalmology Authors: Abraham Nirappel Emma Klug Rebecca Ye Nathan Hall Marika Chachanidze Ta C Chang David Sol á-Del Valle Source Type: research
